SLC3A2 and breast carcinoma: Also, in estrogen-receptor (ER) positive breast cancer cells, it was revealed that co-expression of SLC7A5/SLC3A2 leads to increased proliferation in cancer cells and is associated with poor prognosis, while their knocking down using siRNA-sensitized breast cancer cells to tamoxifen.